Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease
Recruiting · NCT07775352 · Interventional (participants receive a specific treatment) · Lead sponsor: Mahidol University
View the official record on ClinicalTrials.gov →Interventions studied
Intestinal ultrasound (IUS)Standard of care
What this trial is about
This randomized controlled trial evaluates whether adding point-of-care intestinal ultrasound (IUS) to standard of care changes clinical management in patients with inflammatory bowel disease (IBD). Adult patients with Crohn's disease or ulcerative colitis undergoing colonoscopy for disease assessment are randomized 1:1 to standard of care plus IUS at every visit, or standard of care alone, and followed for 48 weeks. The primary outcome is the proportion of patients with a change in treatment.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of inflammatory bowel disease for more than 2 months
- Age 18 years or older
- Undergoing endoscopy at enrollment for assessment of disease severity
Exclusion criteria
- Pregnancy
- Unstable underlying medical conditions
- Inflammatory bowel disease limited to the distal rectum (within 10 cm of the anal verge) or perianal disease only
- Biologic failure
Where it is running
2 locations listed.
- Faculty of Medicine Siriraj Hospital, Mahidol University - Bangkok, Thailand
- Faculty of Medicine Siriraj Hospital, Mahidol University - Bangkok, Thailand